The generic version of Paxlovid, an anti-viral medication made by Hyderabad-based Zenara Pharma, has been approved for manufacture and sale by India’s drug authority for patients with mild to moderate Covid-19 symptoms.
Department of Pharmaceuticals (DoP) is compiling information on local producers of vaccines and biopharmaceuticals raw materials in an effort to improve the nation’s capacity for vaccine manufacturing and examine raw material availability.
GSK committed to offer its pandemic influenza vaccine Adjupanrix to countries through a framework contract negotiated with the European Commission’s Health Emergency Preparedness and Response Authority (HERA) and supply of 85 million doses of the vaccine.
In the first quarter of 2022, which concluded in June, Biocon Limited, in comparison to the same time previous year, its consolidated revenues climbed by 21.5% to Rs. 2,140 crore from Rs. 1,761 crore.
Govt of Jharkhand has created a State Drug Procurement Policy (SDPP) that reserves 30% of the total drugs purchased by the government for local manufacturers, following the model of the central government’s flagship Make in India programme.
Sun Pharmaceutical Industries Ltd., a leading pharmaceutical company, is anticipated to report strong annual revenues in the April-June quarter (Q1FY23), up from Rs 9,719 crores the previous year to Rs 10,383 crores.
Belimumab has been given FDA approval to
treat children with active lupus nephritis who
are simultaneously getting conventional
medication. GlaxoSmithKline is responsible for
both the drug’s production and marketing.